Related Experiment Video
Updated: Aug 14, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Is slow coronary flow associated with inflammation?
Jian-Jun Li1, Bo Xu, Zi-Cheng Li
1Center for Diagnosis and Treatment of Coronary Artery Disease, Fu Wai Hospital, Department of Cardiology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China. lijnjn@yahoo.com.cn
Insights
Coronary slow flow phenomenon, a condition causing chest pain without significant blockages, is not well understood. Emerging research suggests inflammation may play a key role in its development, warranting further investigation.
Area of Science:
- Cardiology
- Pathophysiology
- Inflammation research
Background:
- Coronary slow flow phenomenon (CSFP) presents as delayed contrast transit in coronary arteries without epicardial stenosis.
- First described in 1972, CSFP remains poorly understood with uncertain pathophysiological mechanisms.
- Hypotheses include early atherosclerosis, small vessel dysfunction, and imbalances in vasoactive factors.
Purpose of the Study:
- To explore the potential role of inflammation in the development of coronary slow flow phenomenon.
- To investigate the relationship between inflammatory processes and CSFP.
- To determine if CSFP represents a distinct inflammatory coronary artery disease.
Main Methods:
- Review of existing literature on CSFP and inflammation.
- Analysis of proposed pathophysiological mechanisms.
- Discussion of current evidence linking inflammation to CSFP.
Main Results:
- Inflammation is increasingly recognized as crucial in atherosclerosis development and progression.
- New evidence suggests a potential involvement of inflammatory pathways in CSFP.
- CSFP can lead to angina, myocardial infarction, and hypertension, impacting quality of life.
Conclusions:
- The exact role of inflammation in CSFP requires further investigation.
- CSFP may represent a distinct inflammatory coronary artery disease.
- Understanding CSFP's mechanisms is crucial for managing patient symptoms and quality of life.
Abstract:
Cardiologists are familiar with the phenomenon of slow progression of angiographic contrast in the coronary arteries in the absence of stenosis in the epicardial vessels in some patients presenting with chest pain. This phenomenon is called as coronary slow flow phenomenon, and firstly described in 1972, while it remains scantily studied. The pathophysiological mechanisms of coronary slow flow phenomenon remain uncertain. Several hypotheses however, have been suggested for slow coronary flow phenomenon, including a form of early phase of atherosclerosis, small vessel dysfunction, Hagen-Poiseuille's equation model, imbalance between vasoconstrictor and vasodilatory factors, and platelet function disorder. More recently, there has been mounting evidence that inflammation plays an important role in the initiation, development as well as evolution of atherosclerosis, suggesting that atherosclerosis is an inflammation disease. New evidence has also indicated that inflammation may be involved in the development of slow coronary flow phenomenon. Coronary slow flow phenomenon is an important clinical entity because it may be the cause of angina at rest or during exercise, acute myocardial infarction, and hypertension. Despite the good prognosis of this kind of patients, the chronic, frequent nature of the persistent uncomfortable chest can significantly impair the quality of life. Whether this is really a new kind of coronary disease involving in inflammation, however, is still unknown and deserves further investigation.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction
Inflammation
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
